Statin Tx Not Found to Protect Bones Amidst Inflammation

This article originally appeared here.
Share this content:
Statin Tx Not Found to Protect Bones Amidst Inflammation
Statin Tx Not Found to Protect Bones Amidst Inflammation

TUESDAY, Dec. 2, 2014 (HealthDay News) -- Although research has suggested that statins used to treat cardiovascular disease may also reduce the risk of fracture, treatment with rosuvastatin does not reduce the risk of fracture among men and women with evidence of inflammation, according to a new study published online Dec. 1 in JAMA Internal Medicine.

The study included men older than 50 and women older than 60. The study volunteers were followed for up to five years, with a median follow-up of 1.9 years. Almost 18,000 older adults (17,802) were selected to take either rosuvastatin or placebo. Smoking rates, weight, exercise levels, alcohol intake, rates of hypertension, and fracture history were similar in both groups.

Of the 431 fractures during the study, 221 were among those taking rosuvastatin and 210 were among people taking the placebo, the researchers found.

"Our study does not support the use of statin drugs in the doses used for heart disease for the prevention of bone fractures," lead researcher Jessica Peña, M.D., M.P.H., an assistant professor of cardiology at Montefiore Medical Center and the Albert Einstein College of Medicine in New York City, told HealthDay.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »